Tus kws kho mob
Upcoming pharmacy program policy activity effective Nov. 1, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1811 - 1820 ntawm 4269
Tus kws kho mob
BCBSMN_PharmProgPolicyNotifctn_2021-0101v4.pdf
Tus kws kho mob
BC-COM_Med-Drug_Exclusion-LIST_Medcaid-2020-1112.pdf
Tus kws kho mob
QP64R2-20 Update: Medical Drug Update for Viltolarsen (Viltepso)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP107-20 Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP109-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Antiemetic Agents
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Tus kws kho mob
Upcoming_med_policies_effective_Jan_4_ 2021.pdf
Tus kws kho mob
P50R2-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment and Post-Acute Care Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020